Crystal Lake, Illinois, April 29, 2021 — AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported first quarter results for 2021.
First Quarter 2021 Summary
- Reported sales grew 8%; core sales (excluding acquisitions and currency effects) increased 1%
- Strong demand for our innovative food dispensing closures, the passing through of resin costs and currency effects drove double digit growth in reported sales and core sales in the Food + Beverage segment
- Currency effects contributed to reported sales growth in the Pharma segment and core sales were in line with prior year
- Acquisitions and currency effects contributed to reported sales growth in the Beauty + Home segment and core sales declined 3%
- Reported earnings per share totaled $1.24 (an increase of 48% compared to the prior year)
- Reported earnings per share included a non-cash gain of $0.19 per share related to an increase in the fair value of an equity investment
- Adjusted earnings per share, excluding restructuring charges ($0.04 per share) and the gain on an equity investment, totaled $1.09 (an increase of 10% compared to the prior year when neutralizing currency effects)
- Tax expense was reduced in the quarter due to certain benefits, primarily deductible stock-based compensation
